Search Results 201-210 of 16517 for chondroitin
Rochester, Minn. This protocol is being designed to offer testicular tissue cryopreservation to male pediatric patients (0-17 years of age) with fertility ...
... . VID-20381052. Home; Pharmacogenomics. Have 2X the impact! Give Today. The deadline to have twice the impact to advance healthcare research is May 15.
Subjects must not be eligible for therapy of higher curative potential where an alternative treatment has been shown to prolong survival in an analogous ...
... . VID-20400963. Home; Mayo Clinic Division of Endocrinology - Depth and Breadth of Endocrine Expertise. Have 2X the impact!
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.
There are many reasons that a patient might need a transplant. Some families have known that their baby has a heart defect, even during the pregnancy. And ...
... . VID-20129674. Home; Brightcove- Rotator Cuff_Tom Lutz Story. Have 2X the impact! Give Today. The deadline to have twice the impact to advance ...
The purpose of this study is: To Evaluate and validate the Roche Coaguchek XS Plus analyzer at MCA to replace the ITC Hemochron Jr. Signature + for ...
The purpose of this study is to compare the effects on low-risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no ...
Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.